Lucina
acquired by Unified Womens HealthcareSanta Cruz, US · 1 known investors
Lucina Biotherapeutics develops therapeutics to treat aging-related disorders, particularly dry age-related macular degeneration (AMD), by restoring very long-chain polyunsaturated fatty acids (VLC-PUFAs) in tissues through its PUFActive platform. The company employs two approaches: synthetic VLC-PUFA formulations for intravitreal injection and engineered microorganism biofactories for oral delivery.
BiotechLongevityMedical Devices
Founders & leadership
CC
Christopher ChavezCo-Founder and Chief Executive Officer
DS
Dorota Skowronska-KrawczykScientific Co-Founder
ME
Marty Emanuele
J
Jeanette
D
David
Investors · 1
In the news
Frequently asked questions
- What does Lucina do?
- Lucina Biotherapeutics develops therapeutics to treat aging-related disorders, particularly dry age-related macular degeneration (AMD), by restoring very long-chain polyunsaturated fatty acids (VLC-PUFAs) in tissues through its PUFActive platform. The company employs two approaches: synthetic VLC-PUFA formulations for intravitreal injection and engineered microorganism biofactories for oral delivery.
- Who founded Lucina?
- Lucina was founded by Christopher Chavez, Dorota Skowronska-Krawczyk, Marty Emanuele.
- Who are Lucina's investors?
- Lucina's investors include StartX.
- Who acquired Lucina?
- Lucina was acquired by Unified Womens Healthcare.
- Where is Lucina headquartered?
- Lucina is headquartered in Santa Cruz, US.